RT Journal Article SR Electronic T1 Non-invasive estimation of pressure drop across aortic coarctations: validation of 0D and 3D computational models with in vivo measurements JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2023.09.05.23295066 DO 10.1101/2023.09.05.23295066 A1 Nair, Priya J. A1 Pfaller, Martin R. A1 Dual, Seraina A. A1 McElhinney, Doff B. A1 Ennis, Daniel B. A1 Marsden, Alison L. YR 2023 UL http://medrxiv.org/content/early/2023/09/06/2023.09.05.23295066.abstract AB Purpose Blood pressure gradient (ΔP) across an aortic coarctation (CoA) is an important measurement to diagnose CoA severity and gauge treatment efficacy. Invasive cardiac catheterization is currently the gold-standard method for measuring blood pressure. The objective of this study was to evaluate the accuracy of ΔP estimates derived non-invasively using patient-specific 0D and 3D deformable wall simulations.Methods Medical imaging and routine clinical measurements were used to create patient-specific models of patients with CoA (N=17). 0D simulations were performed first and used to tune boundary conditions and initialize 3D simulations. ΔP across the CoA estimated using both 0D and 3D simulations were compared to invasive catheter-based pressure measurements for validation.Results The 0D simulations were extremely efficient (∼15 secs computation time) compared to 3D simulations (∼30 hrs computation time on a cluster). However, the 0D ΔP estimates, unsurprisingly, had larger mean errors when compared to catheterization than 3D estimates (12.1 ± 9.9 mmHg vs 5.3 ± 5.4 mmHg). In particular, the 0D model performance degraded in cases where the CoA was adjacent to a bifurcation. The 0D model classified patients with severe CoA requiring intervention (defined as ΔP ≥ 20 mmHg) with 76% accuracy and 3D simulations improved this to 88%.Conclusion Overall, a combined approach, using 0D models to efficiently tune and launch 3D models, offers the best combination of speed and accuracy for non-invasive classification of CoA severity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by the Vera Moulton Wall Center for Pulmonary Vascular Disease at Stanford University. PJN is supported by the National Science Foundation Graduate Research Fellowship (DGE-1656518) and MRP is supported by the Stanford Maternal and Child Health Research Institute and the National Institutes of Health (K99HL161313).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All patient data used in this study was acquired as part of the usual clinical care for the patients. The IRB of Stanford University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the study will be publicly available in the Vascular Model Repository (vascularmodel.org) http://vascularmodel.org/